Precision PRP Therapy and Photobiomodulation for Healing

Unlock the potential of precision PRP with photobiomodulation for enhanced treatment outcomes and accelerated healing in various conditions.

Abstract

In this educational post, I will guide you through the latest advancements in regenerative medicine, specifically focusing on the preparation and application of platelet-rich plasma (PRP) and protein concentrates. We will delve into the critical aspects of achieving high-quality PRP, including elevated platelet recovery rates and the versatility of modern systems to dial in specific dosages. I will provide a detailed, data-driven example from my clinic to illustrate these concepts. Furthermore, we will explore the often-overlooked value of platelet-poor plasma (PPP) and how we can transform it into a potent protein concentrate rich in anti-inflammatory and regenerative molecules, such as Alpha-2-Macroglobulin (A2M) and IL-1ra. I will walk you through the precise procedural steps for this concentration process. The discussion will also cover essential pre-procedure patient preparation, ultrasound-guided injection techniques for the acromioclavicular (AC) joint, and comprehensive post-procedure care protocols, including the role of laser therapy. As an integrative practitioner, I will explain how these advanced orthobiologic treatments are synergistic with foundational care, such as chiropractic adjustments, to optimize patient outcomes by addressing both biochemical and biomechanical dysfunctions. Finally, we will address common clinical questions regarding patient case management and the safety of adjunctive therapies like photobiomodulation.

The Pursuit of High-Quality Platelet-Rich Plasma (PRP)

As a clinician dedicated to providing the best possible outcomes for my patients, the quality of the orthobiologics I use is paramount. It’s not enough to draw blood and spin it in a centrifuge; we must be precise and scientific in our approach. My focus is on several key metrics that define a superior PRP product.

Key Metrics for Superior PRP

• Elevated Platelet Recovery: The primary goal is to capture the maximum number of platelets from the whole blood sample. The system I utilize boasts an average platelet recovery of about 83%. This is a significant figure to consider, given that some platelets will inevitably remain in the plasma fraction and others within the red blood cell (RBC) stack after centrifugation. A high recovery rate ensures we are delivering a potent therapeutic dose.
• Versatility and Control: A one-size-fits-all approach doesn’t work in regenerative medicine. The ability to customize the treatment for each patient and their specific condition is crucial. I value a system that allows me to precisely control not just the final volume of the injectate but also its composition by selectively harvesting from the buffy coat and the upper layers of the RBC stack. This gives me the flexibility to dial in the exact cellular mix—be it leukocyte-rich or leukocyte-poor—that the pathology requires.
• Dose and Concentration: Reproducibility is key to consistent results. With a single 60 cc blood draw, the system I use yields an average platelet dose of approximately 8 billion platelets. For those accustomed to thinking in terms of concentration folds, this translates to roughly a 10-fold concentration increase from the patient’s baseline platelet count. Knowing the exact dose allows for predictable and evidence-based treatment.

A Clinical Data Deep Dive

To illustrate these points, let’s look at real-world data from my clinic. I believe in measuring, not guessing, to ensure I’m delivering what I promise.

Here is a breakdown of a sample we recently processed:

• Whole Blood Analysis:

• • Initial Platelet Count: 265,000 platelets/µL
  • Total Platelets in 60 cc draw: (265,000 x 60,000) = 9 billion platelets

• Final PRP Product:

• • Volume: 7 cc
  • PRP Platelet Count: 2,128,000 platelets/µL
  • Total Platelets in Injectate: (2,128,000 x 7,000) = 89 billion platelets

In this specific case, we achieved an outstanding 94% platelet recovery rate. This is the level of precision we should all be striving for. But the analysis doesn’t stop there. We also need to look at what we’ve successfully filtered out. Notice the significant reduction in granulocytes (a type of pro-inflammatory white blood cell) and, critically, the near-total elimination of RBCs, with a measurement of less than 0.1 in the final product. This is vital because a high RBC concentration can be pro-inflammatory and irritating to joints. By meticulously analyzing the dose and cellular makeup, I can confidently and accurately tailor the treatment for each individual.

Maximizing Therapeutic Potential: Creating Protein Concentrate from PPP

Historically, many of us in this field would discard the platelet-poor plasma (PPP) after separating the PRP. We considered it a byproduct. However, current research has illuminated the immense therapeutic value hiding within this “liquid gold.” PPP is not just water; it contains a wealth of beneficial proteins and a smaller, yet significant, number of platelets.

What’s Inside Platelet-Poor Plasma?

• Alpha-2-Macroglobulin (A2M): A large, powerful protease inhibitor.
• Hepatocyte Growth Factor (HGF): Promotes cell regeneration.
• Soluble TNF-α Receptor (sTNF-R): Binds to and neutralizes the inflammatory cytokine TNF-alpha.
• Platelet-Derived Growth Factor (PDGF-BB): A potent mitogen for cells of mesenchymal origin.
• Interleukin-1 Receptor Antagonist (IL-1ra): A natural anti-inflammatory protein that blocks the action of the highly inflammatory IL-1.
• Epidermal Growth Factor (EGF): Stimulates cell growth and differentiation.

By using a specialized filtration system, we can concentrate these valuable components. The process involves a 15-kilodalton filter that allows us to dehydrate the PPP, reducing its volume by about 75%. This concentrates the proteins and allows us to “scavenge” an additional 1.6 billion platelets that were left behind in the plasma. The result is a powerful protein concentrate with:

• 5x baseline concentration of A2M.
• 2x baseline concentration of sTNF-R.
• A clinically significant 100:1 ratio of anti-inflammatory IL-1ra versus the pro-inflammatory IL-1β.

The Science Behind Protein Concentrate in Osteoarthritis

This protein concentrate is a game-changer, especially in the fight against osteoarthritis (OA). The chronic inflammation in an osteoarthritic joint is driven by a vicious cycle of catabolic (breakdown) processes.

• The Role of A2M: The A2M molecule is a massive 720 kilodaltons, which means it cannot easily migrate from the bloodstream into the synovial fluid of the joint on its own. When we inject the concentrate directly into the joint, A2M acts like a “Venus flytrap.” It lures and irreversibly binds to catabolic enzymes (such as matrix metalloproteinases, or MMPs) responsible for breaking down cartilage. By neutralizing these degradative enzymes, A2M creates a negative feedback loop, mitigating the destructive effects of chronic inflammation and protecting the remaining cartilage.
• The Power of IL-1ra: The cytokine Interleukin-1 (IL-1) is a primary driver of pain and inflammation in OA. Our concentrated injectate delivers a high dose of IL-1 receptor antagonist protein (IL-1ra). This protein floods the joint and competitively binds to the IL-1 receptors on cartilage cells (chondrocytes) and synovial cells. By occupying these receptors, it physically prevents the destructive IL-1 from docking and initiating its inflammatory cascade. This directly reduces pain and inflammation within the joint.

The Patient Journey: Pre-Procedure Optimization and Consultation

A successful orthobiologic procedure begins long before the needle enters the skin. My patient consultations are thorough, typically lasting around 36 minutes, because a comprehensive approach is non-negotiable. This time is dedicated to securing the right diagnosis, discussing all available treatment options—from conservative to surgical—and collaboratively deciding on the most viable path forward.

Stacking the Deck for Success

I believe in doing everything possible to stack the deck in my patient’s favor. This involves a multifaceted pre-procedure optimization strategy:

• Medication Management:

• • Steroid Injections: We need to know the timing of any prior steroid injections, as they can adversely affect local tissues and cellular function.
  • Anti-inflammatories (NSAIDs): Ideally, patients should stop common NSAIDs like ibuprofen (Advil) or naproxen (Aleve) as they can interfere with platelet function. If a patient cannot completely cease anti-inflammatory use, recent studies suggest that meloxicam may be more compatible with orthobiologic treatments. I will often transition patients to this if needed.

• • Supplementation: For patients who come off NSAIDs, we can recommend alternative supplements that help manage pain and OA symptoms without disrupting platelet function. We also use specific supplements to enhance overall cellular health and cellular metabolism, priming the body’s systems for an optimal healing response.
  • Hydration and Nutrition: We instruct patients to begin hydrating well at least two days before their blood draw. A healthy breakfast is generally recommended on the day of the procedure. While there is some emerging, though still controversial, discussion about the potential benefits of intermittent fasting for PRP output, my current standard is to ensure the patient is well-nourished and hydrated.
  • Informed and Financial Consent: Transparency is crucial. We have an open discussion about the cost of the procedure, as most orthobiologic treatments are not reimbursed by insurance. For Medicare patients, it is a requirement that they sign an Advanced Beneficiary Notice (ABN) prior to any injection-based procedure.

Precision in Practice: Ultrasound-Guided AC Joint Injection

Now, let’s move to the procedure itself. Here, I’ll walk you through my technique for an acromioclavicular (AC) joint injection. I almost always perform these injections with the patient seated, which I find enhances efficiency, especially when treating multiple structures in the shoulder. However, it’s crucial to be prepared for a potential vasovagal (fainting) response and be ready to quickly move the patient to a lateral decubitus (side-lying) position if needed.

Step-by-Step AC Joint Injection Technique

1. Patient Positioning and Planning: The patient is seated. My typical workflow for a comprehensive shoulder treatment is to work from back to front. After administering an interscalene nerve block for anesthesia, I begin with a posterior glenohumeral joint injection.
2. Targeting the AC Joint: Next, I address the AC joint. I use an out-of-plane technique, placing the ultrasound transducer on the anterior shoulder. This allows me to visualize the joint clearly while keeping the needle path hidden from the patient’s view, as I enter from the posterior aspect.
3. Site Preparation: I mark the injection site and prep the skin thoroughly with Betadine and alcohol. The area has already been anesthetized.
4. Ultrasound Visualization: I place the AC joint directly in the center of the ultrasound screen. The target is a “V” shape formed by the clavicle and the acromion.
5. Needle Entry and Advancement: Using a 25-gauge needle, I triangulate the injection, advancing from posterior to anterior. On the screen, the goal is to see the needle tip appear as a bright white dot right in the joint space.
6. Injection and Confirmation: Once the needle tip is confirmed to be in the ideal position, I inject the PRP. You can clearly see the fluid flow distending the joint capsule on the ultrasound monitor. The AC joint typically holds between 0.6 and 1.1 cc of fluid. A free and easy flow confirms accurate placement.

Following the AC joint, I can then move anteriorly to address other structures like the infraspinatus insertion, supraspinatus tendon, subscapularis, and biceps tendon in both long and short axis views. This systematic back-to-front approach is highly efficient.

Post-Procedure Care and the Role of Integrative Chiropractic

The healing process is just as important as the procedure itself. A comprehensive post-procedure plan is essential for maximizing results and ensuring a smooth recovery.

• Immobilization and Comfort: For a comprehensive shoulder procedure, we typically place the patient in a sling for one to two days. This serves three purposes: safety, comfort, and advertising to others that they should be careful around the patient.
• Discontinuation of Anti-inflammatories: We advise patients to continue avoiding NSAIDs for at least a couple of weeks post-procedure to allow the therapeutic inflammatory phase of healing to proceed uninterrupted.
• Adjunctive Therapies:

• • Laser Therapy (Photobiomodulation): I am a strong advocate for starting laser therapy the day after the procedure. This therapy accelerates the healing curve by enhancing ATP production for cellular metabolism and promoting nitric oxide release for pain relief. It helps to shorten the duration of the initial, intense inflammatory phase.
  • Heat vs. Ice: We encourage using near-infrared light or moist heat. I generally advise patients to avoid ice if possible. There is a physiological basis for this: cold can slow cellular metabolism and potentially blunt the regenerative response we are trying to stimulate. However, if ice is the only modality a patient can tolerate for post-injection pain, I will allow it.

• • Rehabilitation Protocols: Rehab is critical. A quick and effective way to structure this is to adapt existing post-surgical protocols. For example, following a rotator cuff injection, I would use a standard post-surgical rotator cuff repair protocol, but have the patient start at the 6-week mark. This bypasses the initial immobilization phase and moves directly into gentle range-of-motion and strengthening.

The Integrative Chiropractic Connection

As a practitioner with credentials in both chiropractic (DC) and as a nurse practitioner (APRN), I see the body as an interconnected system. Orthobiologic treatments are incredibly powerful for addressing the biochemical and cellular aspects of tissue damage and inflammation. However, we cannot ignore the biomechanical component.

If a patient has an arthritic AC joint, it is often related to underlying scapular dyskinesis, poor thoracic posture, or dysfunction in the cervical spine. Chiropractic care is essential for addressing these root biomechanical faults. By performing specific adjustments to the thoracic spine, mobilizing the scapula, and restoring proper cervical alignment, we improve the overall mechanics of the shoulder girdle. This reduces abnormal stress on the healing AC joint and creates a more favorable environment for the PRP to work effectively.

Treating the biochemical inflammation with PRP while simultaneously correcting the biomechanical dysfunction with chiropractic care is a truly integrative approach. It ensures we are not just patching a symptom but addressing the entire pathological process, leading to more durable outcomes for our patients. This synergy is at the heart of my clinical philosophy.

References

Cuomo, F., & Zuke, W. A. (2020). Orthobiologics: A comprehensive guide for clinical practice. Springer.

Dhillon, M. S., Patel, S., & John, R. (2017). PRP in OA knee – update, current evidence and future directions. Journal of Clinical Orthopedics and Trauma, 8(1), 11-16. https://doi.org/10.1016/j.jcot.2017.02.007

Laudy, A. B., Bakker, E. W. P., Rekers, M., & Moen, M. H. (2015). Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. British Journal of Sports Medicine, 49(10), 657-665. https://doi.org/10.1136/bjsports-2014-094036

Mautner, K., Blazuk, J., & Shiple, B. (2021). The use of alpha-2-macroglobulin in the treatment of joint and disc pain. In L. S. Miller & D. A. D. Arrow (Eds.), Regenerative Medicine. Elsevier.

Ornetti, P., Nourissat, G., Berenbaum, F., & Sellam, J. (2016). Does platelet-rich plasma have a role in the treatment of osteoarthritis? Joint Bone Spine, 83(1), 31-36. https://doi.org/10.1016/j.jbspin.2015.06.002

Zeisig, E., Fahlström, M., Ohberg, L., & Alfredson, H. (2011). Pain relief after intratendinous injections in patients with tennis elbow: results of a randomized controlled study. British Journal of Sports Medicine, 45(8), 639-644. https://doi.org/10.1136/bjsm.2010.081197

SEO Tags: Platelet-Rich Plasma, PRP, Protein Concentrate, Orthobiologics, Regenerative Medicine, Osteoarthritis Treatment, Dr. Alex Jimenez, AC Joint Injection, Ultrasound-Guided Injection, Integrative Chiropractic, Photobiomodulation, Laser Therapy, Alpha-2-Macroglobulin, A2M, IL-1ra, Cellular Metabolism, Functional Medicine, Shoulder Pain, Knee Pain, Joint Health, Non-Surgical Treatment